BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 38581008)

  • 1. REEP3 is a potential diagnostic and prognostic biomarker correlated with immune infiltration in pancreatic cancer.
    Liu GH; Tan XY; Xu ZY; Li JX; Zhong GH; Zhai JW; Li MY
    Sci Rep; 2024 Jun; 14(1):13834. PubMed ID: 38879709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of fibronectin type III domain containing 3B as a potential prognostic and therapeutic target for pancreatic cancer: a preliminary analysis.
    Wang Y; Kong Y; Yang Q; Zhong C; Zhou D
    Eur J Med Res; 2024 Apr; 29(1):221. PubMed ID: 38581008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collagen type VII α1 chain: A promising prognostic and immune infiltration biomarker of pancreatic cancer.
    Ding C; Yu Z; Li X; Zhu J; Dai M; He Q
    Oncol Lett; 2023 Feb; 25(2):77. PubMed ID: 36742365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FNDC3B is associated with ER stress and poor prognosis in cervical cancer.
    Han B; Wang H; Zhang J; Tian J
    Oncol Lett; 2020 Jan; 19(1):406-414. PubMed ID: 31897153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipase A/acyltransferase 4 is a prognostic biomarker and correlated with immune infiltrates in pancreatic cancer.
    Li TH; Wang YY; Zhao BB; Qin C; Li ZR; Wang WB
    Heliyon; 2022 Sep; 8(9):e10416. PubMed ID: 36091946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated machine learning methods identify FNDC3B as a potential prognostic biomarker and correlated with immune infiltrates in glioma.
    Wang X; Huang Y; Li S; Zhang H
    Front Immunol; 2022; 13():1027154. PubMed ID: 36275754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas.
    Tian QS; Zhang Q; Huang W
    Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neoadjuvant radioimmunotherapy in pancreatic cancer enhances effector T cell infiltration and shortens their distances to tumor cells.
    Wang J; Gai J; Zhang T; Niu N; Qi H; Thomas DL; Li K; Xia T; Rodriguez C; Parkinson R; Durham J; McPhaul T; Narang AK; Anders RA; Osipov A; Wang H; He J; Laheru DA; Herman JM; Lee V; Jaffee EM; Thompson ED; Zhu Q; Zheng L
    Sci Adv; 2024 Feb; 10(6):eadk1827. PubMed ID: 38324679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer statistics, 2024.
    Siegel RL; Giaquinto AN; Jemal A
    CA Cancer J Clin; 2024; 74(1):12-49. PubMed ID: 38230766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibronectin Type III Domain Containing 3B as a Potential Prognostic and Therapeutic Biomarker for Glioblastoma.
    Kwon H; Yun M; Kwon TH; Bang M; Lee J; Lee YS; Ko HY; Chong K
    Biomedicines; 2023 Nov; 11(12):. PubMed ID: 38137388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nanodrug simultaneously inhibits pancreatic stellate cell activation and regulatory T cell infiltration to promote the immunotherapy of pancreatic cancer.
    Wang R; Hong K; Zhang Q; Cao J; Huang T; Xiao Z; Wang Y; Shuai X
    Acta Biomater; 2023 Oct; 169():451-463. PubMed ID: 37572982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RRM1 is mediated by histone acetylation through gemcitabine resistance and contributes to invasiveness and ECM remodeling in pancreatic cancer.
    Ono H; Murase Y; Yamashita H; Kato T; Asano D; Ishikawa Y; Watanabe S; Ueda H; Akahoshi K; Ogawa K; Kudo A; Akiyama Y; Tanaka S; Tanabe M
    Int J Oncol; 2023 Apr; 62(4):. PubMed ID: 36866763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conditional Knockout of Hypoxia-Inducible Factor 1-Alpha in Tumor-Infiltrating Neutrophils Protects against Pancreatic Ductal Adenocarcinoma.
    Sieow JL; Penny HL; Gun SY; Tan LQ; Duan K; Yeong JPS; Pang A; Lim D; Toh HC; Lim TKH; Engleman E; Rotzschke O; Ng LG; Chen J; Tan SM; Wong SC
    Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614196
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.